Breathing test may Fine-Tune antibody doses for immune deficiency patients

NCT ID NCT05193552

First seen May 13, 2026 · Last updated May 13, 2026

Summary

This study looks at whether a common breathing test (spirometry) can help doctors decide the best dose of immunoglobulin replacement therapy for people with common variable immune deficiency (CVID) who also have mild airway blockage. About 22 adults on a stable dose will be split into two groups: one stays on their current dose, the other gets a slightly higher dose for 6 months. The goal is to see if the higher dose improves lung function and quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMMON VARIABLE IMMUNODEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Community Health 20

    RECRUITING

    Birmingham, Alabama, 35205, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.